Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 5, 2005 - Issue 6
Submit an article Journal homepage
133
Views
15
CrossRef citations to date
0
Altmetric
Drug Profile

Selegiline orally disintegrating tablets for the treatment of Parkinson’s disease

Mark F Lew Department of Neurology, University of Southern California, Keck School of Medicine, 1520 San Pablo St., HCC 2, Ste, 3000, Los Angeles, CA 90033, USA. [email protected]
Pages 705-712 | Published online: 10 Jan 2014

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Angela M Richmond, Kelly E Lyons & Rajesh Pahwa. (2023) Safety review of current pharmacotherapies for levodopa-treated patients with Parkinson’s disease. Expert Opinion on Drug Safety 22:7, pages 563-579.
Read now
Vinay Sridhar, Sarika Wairkar, Ram Gaud, Amrita Bajaj & Pramod Meshram. (2018) Brain targeted delivery of mucoadhesive thermosensitive nasal gel of selegiline hydrochloride for treatment of Parkinson's disease. Journal of Drug Targeting 26:2, pages 150-161.
Read now
Lawrence W Elmer & John M Bertoni. (2008) The increasing role of monoamine oxidase type B inhibitors in Parkinson's disease therapy. Expert Opinion on Pharmacotherapy 9:16, pages 2759-2772.
Read now

Articles from other publishers (12)

V. R. Timergalieva, A. Yu. Sitenkov, A. V. Sitenkova (Bukhovets), E. S. Elizarova, D. S. Gordeeva, I. I. Semina & R. I. Moustafine. (2023) Development of Lyophilisates Based on Polymer-drug and Interpolyelectrolyte Complexes: Pharmacokinetic Assessment. Drug development & registration.
Crossref
Chandani T. Muleva & Sonali S. Bharate. (2023) Halide counterions in FDA-approved pharmaceutical salts. Journal of Drug Delivery Science and Technology 89, pages 104999.
Crossref
Venera R. Timergalieva, Chiara G. M. Gennari, Francesco Cilurzo, Francesca Selmin & Rouslan I. Moustafine. (2023) Comparative Evaluation of Metformin and Metronidazole Release from Oral Lyophilisates with Different Methods. Scientia Pharmaceutica 91:2, pages 23.
Crossref
Michele Basilicata, Piergiorgio Grillo, Alvise Tancredi, Adolfo Di Fiore, Patrizio Bollero, Alessandro Stefani & Tommaso Schirinzi. (2023) Oral Health and Use of Novel Transbuccal Drug Delivery Systems in Patients with Alzheimer’s and Parkinson’s Disease: A Review. Applied Sciences 13:8, pages 4974.
Crossref
Eva Schaeffer, Andrea Pilotto & Daniela Berg. (2014) Pharmacological Strategies for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease. CNS Drugs 28:12, pages 1155-1184.
Crossref
Mark Stacy. (2009) Medical Treatment of Parkinson Disease. Neurologic Clinics 27:3, pages 605-631.
Crossref
Mickie Welsh. (2008) Treatment Challenges in Parkinson's Disease. The Nurse Practitioner 33:7, pages 32.
Crossref
Lauren C. Seeberger & Robert A. Hauser. (2007) Optimizing bioavailability in the treatment of Parkinson's disease. Neuropharmacology 53:7, pages 791-800.
Crossref
Joseph Jankovic & Mark Stacy. (2007) Medical Management of Levodopa-Associated Motor Complications in Patients with Parkinson???s Disease. CNS Drugs 21:8, pages 677-692.
Crossref
Michael J. O'Neill, Marcus J. Messenger, Viktor Lakics, Tracey K. Murray, Eric H. Karran, Philip G. Szekeres, Eric S. Nisenbaum & Kalpana M. Merchant. 2007. The Pharmacology of Neurogenesis and Neuroenhancement. The Pharmacology of Neurogenesis and Neuroenhancement 179 217 .
. (2006) Laser Literature Watch. Photomedicine and Laser Surgery 24:3, pages 424-453.
Crossref
K. Magyar, M. Pálfi, V. Jenei & É. Szökő. 2006. Oxidative Stress and Neuroprotection. Oxidative Stress and Neuroprotection 143 156 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.